| NCT ID | NCT06361459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Leiden University Medical Center |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2023-07-06 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2023-07-06 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients that are subjected to a medium complex surgical intervention in neck (posterior) or lumbar spine (posterior) with instrumentation are motivated to stop smoking. The outcome data of patients that stop and that continue smoking will be compared. A group of non smokers is evaluated as a control group. Particularly clinical outcome is evaluated, as well as radiological outcome.
Eligibility Criteria
Inclusion Criteria: * candidates for moderately complex instrumented surgery of the neck or low back. Exclusion Criteria: * Patients undergoing surgery for malignancy or trauma are excluded. * non Dutch speaking patients * pregnancy
Frequently Asked Questions
Who can join the NCT06361459 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06361459 currently recruiting?
Yes, NCT06361459 is actively recruiting participants. Visit ClinicalTrials.gov or contact Leiden University Medical Center to inquire about joining.
Where is the NCT06361459 trial being conducted?
This trial is being conducted at Leiden, Netherlands.
Who is sponsoring the NCT06361459 clinical trial?
NCT06361459 is sponsored by Leiden University Medical Center. The trial plans to enroll 210 participants.